Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kubler Ross's Stages of Dying01:21

Kubler Ross's Stages of Dying

Elisabeth Kübler-Ross significantly advanced psychology's understanding of the process of dying with her influential book, On Death and Dying (1969). She focused on studying terminally ill individuals and outlined five stages commonly experienced when coping with death: denial, anger, bargaining, depression, and acceptance.
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from emotional distress. Anger...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are observed.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A role for nucleolin in functional improvement in stroke.

iScience·2026
Same author

Recent advances in the development of selective hMAO-B inhibitors for neurodegenerative diseases: An update from 2020 to present.

European journal of medicinal chemistry·2026
Same author

18 kDa TSPO-mediated neurosteroidogenesis controls cholesterol homeostasis in tuning microglia response to inflammatory stimulus.

Biochimica et biophysica acta. Molecular basis of disease·2026
Same author

Multiple mTOR RNA localization signals regulate subcellular protein synthesis and axonal growth.

bioRxiv : the preprint server for biology·2026
Same author

From Pharmacovigilance Signals to Mechanistic Phenotypes: Integrating ADMET, PK/PD, and Network Context to Interpret Antiviral Safety in Pregnancy.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Reading the SINEs - functionality in noncoding RNA 'cheap genes'.

RNA biology·2026

Related Experiment Video

Updated: Jun 15, 2026

Detecting Anastasis In Vivo by CaspaseTracker Biosensor
20:16

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

On the death Trk.

Liraz Harel1, Barbara Costa, Mike Fainzilber

  • 1Department of Biological Chemistry, Weizmann Institute of Science, 76100 Rehovot, Israel.

Developmental Neurobiology
|February 27, 2010
PubMed
Summary
This summary is machine-generated.

Receptor tyrosine kinases (RTKs) in the Trk family paradoxically promote neuronal survival and induce cell death in pediatric tumors. New research reveals TrkA interaction with CCM2 protein may mediate this cell death, offering prognostic insights.

More Related Videos

High-Throughput Behavioral Aging and Lifespan Assays Using the Lifespan Machine
08:53

High-Throughput Behavioral Aging and Lifespan Assays Using the Lifespan Machine

Published on: January 26, 2024

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
12:55

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis

Published on: February 16, 2015

Related Experiment Videos

Last Updated: Jun 15, 2026

Detecting Anastasis In Vivo by CaspaseTracker Biosensor
20:16

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

High-Throughput Behavioral Aging and Lifespan Assays Using the Lifespan Machine
08:53

High-Throughput Behavioral Aging and Lifespan Assays Using the Lifespan Machine

Published on: January 26, 2024

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
12:55

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis

Published on: February 16, 2015

Area of Science:

  • Neuroscience
  • Oncology
  • Molecular Biology

Background:

  • The Trk family of receptor tyrosine kinases (RTKs) is crucial for nervous system development, supporting neuronal survival and differentiation.
  • Paradoxically, Trk family members can also induce cell death in pediatric tumor cells of neuronal origin, such as neuroblastoma and medulloblastoma.
  • TrkA and TrkC are established as favorable prognostic indicators in neuroblastoma and medulloblastoma, respectively, suggesting a complex role in these cancers.

Purpose of the Study:

  • To investigate the mechanisms underlying the paradoxical induction of cell death by Trk family members in neuronal tumor cells.
  • To explore the potential link between TrkA signaling and cell death pathways, including p75-dependent and independent mechanisms.
  • To elucidate the role of the novel TrkA-CCM2 interaction in Trk-mediated cell death and its clinical relevance in neuroblastoma.

Main Methods:

  • Review of recent findings on TrkA signaling pathways involved in neuronal cell death.
  • Analysis of the interaction between TrkA and CCM2 (cerebral cavernous malformation 2) protein.
  • Examination of cell death induction in medulloblastoma and neuroblastoma cell lines upon coexpression of CCM2 and TrkA.
  • Correlation analysis of CCM2 expression levels with TrkA expression and patient prognosis in neuroblastoma.

Main Results:

  • Recent studies suggest TrkA may induce neuronal cell death via stimulation of p75 cleavage.
  • A novel, p75-independent mechanism involving TrkA interaction with CCM2 has been identified.
  • Coexpression of CCM2 with TrkA triggers cell death in medulloblastoma and neuroblastoma cells.
  • CCM2 expression levels positively correlate with TrkA levels and favorable prognosis in neuroblastoma patients.

Conclusions:

  • Emerging evidence points to TrkA-CCM2 interaction as a key mechanism in Trk-induced neuronal cell death.
  • This interaction provides mechanistic insights into the dual role of Trk signaling in neuronal development and cancer.
  • Further research into these mechanisms and their in vivo significance is warranted for potential therapeutic applications in neuroblastoma and medulloblastoma.